Skip to main content

LISINOPRIL

NDC 60760-357 · St. Mary's Medical Park Pharmacy

Generic nameLisinopril

Dosage formTABLET

RouteORAL

Active ingredient(s)LISINOPRIL

Strength5 mg/1

Pharmacologic classAngiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]

Marketing categoryANDA

Packages

60760-357-90 — 90 TABLET in 1 BOTTLE, PLASTIC (60760-357-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

55154-8096 — Lisinopril, 55289-884 — Lisinopril, 55700-479 — Lisinopril, 55700-547 — Lisinopril, 60687-325 — Lisinopril, 60687-333 — Lisinopril, 60687-656 — Lisinopril, 60687-667 — Lisinopril, 60687-678 — Lisinopril, 60760-063 — LISINOPRIL AND HYDROCHLOROTHIAZIDE, 60760-358 — Lisinopril, 60760-359 — Lisinopril, 60760-360 — Lisinopril, 60760-519 — Lisinopril and Hydrochlorothiazide Tablets, 60760-586 — Lisinopril and Hydrochlorothiazide Tablets, 62135-640 — Lisinopril, 62135-641 — Lisinopril, 62135-642 — Lisinopril, 62135-643 — Lisinopril, 62135-644 — Lisinopril, +342 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels